These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 34923203)
1. Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach. Marks S; Naidoo J Lung Cancer; 2022 Jan; 163():59-68. PubMed ID: 34923203 [TBL] [Abstract][Full Text] [Related]
2. Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers. Somme LB; Chouaid C; Moinard-Butot F; Barbe-Richaud JB; Greillier L; Schott R BioDrugs; 2024 Jul; 38(4):487-497. PubMed ID: 38767823 [TBL] [Abstract][Full Text] [Related]
3. Antibody-Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class. Marks JA; Wilgucki M; Liu SV; Reuss JE Curr Oncol Rep; 2022 Dec; 24(12):1829-1841. PubMed ID: 36197593 [TBL] [Abstract][Full Text] [Related]
4. Antibody Drug Conjugates in Lung Cancer. Merle G; Friedlaender A; Desai A; Addeo A Cancer J; 2022 Nov-Dec 01; 28(6):429-435. PubMed ID: 36383905 [TBL] [Abstract][Full Text] [Related]
5. TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC). Parisi C; Mahjoubi L; Gazzah A; Barlesi F Cancer Treat Rev; 2023 Jul; 118():102572. PubMed ID: 37230055 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC). Abuhelwa Z; Alloghbi A; Nagasaka M Cancer Treat Rev; 2022 May; 106():102393. PubMed ID: 35472631 [TBL] [Abstract][Full Text] [Related]
9. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments. Reuss JE; Gosa L; Liu SV Clin Lung Cancer; 2021 Nov; 22(6):483-499. PubMed ID: 34420859 [TBL] [Abstract][Full Text] [Related]
10. The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy. Liu X; Deng J; Zhang R; Xing J; Wu Y; Chen W; Liang B; Xing D; Xu J; Zhang M Front Immunol; 2023; 14():1335252. PubMed ID: 38162667 [TBL] [Abstract][Full Text] [Related]
11. Pioneering the Way: The Revolutionary Potential of Antibody-Drug Conjugates in NSCLC. Chen X; Zeng C Curr Treat Options Oncol; 2024 Apr; 25(4):556-584. PubMed ID: 38520605 [TBL] [Abstract][Full Text] [Related]
12. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Damelin M; Bankovich A; Bernstein J; Lucas J; Chen L; Williams S; Park A; Aguilar J; Ernstoff E; Charati M; Dushin R; Aujay M; Lee C; Ramoth H; Milton M; Hampl J; Lazetic S; Pulito V; Rosfjord E; Sun Y; King L; Barletta F; Betts A; Guffroy M; Falahatpisheh H; O'Donnell CJ; Stull R; Pysz M; Escarpe P; Liu D; Foord O; Gerber HP; Sapra P; Dylla SJ Sci Transl Med; 2017 Jan; 9(372):. PubMed ID: 28077676 [TBL] [Abstract][Full Text] [Related]
13. Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation. Zhao C; Zhang R; Yang H; Gao Y; Zou Y; Zhang X Biochem Pharmacol; 2024 Aug; 226():116378. PubMed ID: 38908529 [TBL] [Abstract][Full Text] [Related]
14. The Rise of the TROP2-Targeting Agents in NSCLC: New Options on the Horizon. Ahmed Y; Berenguer-Pina JJ; Mahgoub T Oncology; 2021; 99(10):673-680. PubMed ID: 34280931 [TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates in advanced lung cancer: Is this a new frontier? Reuss JE; Rosner S; Levy BP Clin Adv Hematol Oncol; 2024 Jun; 22(5):217-226. PubMed ID: 38805313 [TBL] [Abstract][Full Text] [Related]
17. Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies. Passaro A; Jänne PA; Peters S J Clin Oncol; 2023 Jul; 41(21):3747-3761. PubMed ID: 37224424 [TBL] [Abstract][Full Text] [Related]
18. [Research Progress of Antibody-conjugated Drugs in Non-small Cell Lung Cancer]. Liu Y; Wei S Zhongguo Fei Ai Za Zhi; 2024 Jun; 27(6):431-440. PubMed ID: 39026494 [TBL] [Abstract][Full Text] [Related]
19. [Research Progress of Antibody-drug Conjugates in Advanced Non-small Cell Lung Cancer]. Wang N; Zhao L; Zhang D; Jia Y; Kong F Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):214-218. PubMed ID: 35340165 [TBL] [Abstract][Full Text] [Related]
20. Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors. Nelson BE; Meric-Bernstam F Annu Rev Med; 2024 Jan; 75():31-48. PubMed ID: 37758237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]